Skip to main content

Table 1 The stimuli-responsive release of drugs loaded on different nanocarriers

From: Current trends and challenges in cancer management and therapy using designer nanomaterials

Stimuli

Nanocarriers

Drug

Target

References

pH

Hybrid micelles

Doxorubicin

Breast cancer

[72]

Mesoporous silica nanoparticles

Doxorubicin

Cervical cancer

[73]

Dendrimers

Doxorubicin

Breast cancer

[74]

Coordination polymer mesoporous silica nanoparticles

Topotecan

Cervical carcinoma

[75]

Gold nanocages

Doxorubicin

Breast cancer

[76]

Chitosan nanoparticles

Tamoxifen

Breast cancer

[77]

Polymeric nanoparticles

Cisplatin

Ovarian cancer

[78]

Titanium dioxide nanoparticles

Daunorubicin

Leukemia

[79]

Redox

Mesoporous silica nanoparticles

Doxorubicin

Glioblastoma

[80]

Polymeric conjugates

Doxorubicin

Hepatocellular carcinoma

[81]

Polymeric nanoparticles

Camptothecin, doxorubicin

Breast cancer

[82]

Magnetic micelles

Doxorubicin

Hepatocarcinoma

[83]

Chitosan nanoparticles

Methotrexate

Cervical cancer

[84]

Gold nanoparticles

Doxorubicin, methotrexate, 6-mercaptopurine

Cervical, lung carcinoma

[85]

Block copolymer nanoparticles

Doxorubicin

Lung cancer

[86]

Magnetic field

Magnetite nanoparticles

Doxorubicin

Multiple myelomas

[87]

Magnetic nanoparticles

Doxorubicin

Liver cancer

[88]

Iron oxide nanoparticles

Homocamptothecin

Squamous cell carcinoma

[89]

PMAM-magnetite nanocrystallites

Cisplatin

Colon adenocarcinoma

[90]

Superparamagnetic iron oxide nanoparticles

Valrubicin

Prostate cancer

[91]

Magnetic nanoparticles

Doxorubicin

Cervical cancer

[92]

Light

Mesoporous bamboo charcoal nanoparticles

Doxorubicin

Breast cancer

[93]

Telluride PEG co-block polymeric nanoparticles

Cisplatin

Breast cancer

[94]

TiO2–iron oxide nanoparticles

Artemisinin

Breast cancer

[95]

Chitosan-based nanocarrier

Camptothecin

Breast cancer

[96]

Temperature

Liposomes

Tamoxifen, imatinib

Breast cancer

[97]

β-Cyclodextrin star polymer

Paclitaxel, doxorubicin

Liver cancer

[98]

Polysaccharide based nanogels

Doxorubicin

Cervical cancer

[99]

  1. Specific nanocarriers, drug and targeted cancer have also been shown in the table